Market News & Trends
Catalent Acquires Pharmapak, Australia
Catalent Pharma Solutions recently announced it has acquired Pharmapak Technologies Pty Ltd., a leading pharmaceutical packaging business based in New South Wales, Australia. Enhancing Catalent’s…
Althea's New Drug Formulation Technology Gains Attention from Two More Top Pharmaceutical Companies
Ajinomoto Althea, Inc. (Althea) recently announced it has added two more top pharmaceutical companies to its growing list of partners in developing and manufacturing cGMP-produced…
Aptar Pharma Twister® Chosen for Asthma Therapy
Louveciennes, France - Aptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products…
TPG Completes Acquisition of Aptalis Pharmaceutical Technologies, Company Renamed Adare
BRIDGEWATER, New Jersey and FORT WORTH, Texas – Aptalis Pharmaceutical Technologies recently announced that its divestiture from Actavis plc to TPG, a global…
Development & Commercialization of Antibacterial Drugs to Speed Up
The growing threat posed by multi-drug resistant gram-negative organisms (MDR-GNBs) is lending a sense of urgency to the development of antibacterial drugs worldwide. Upcoming regulatory…
US Rheumatoid Arthritis Treatment Market Value to Reach $9.3 Billion
The US treatment market for Rheumatoid Arthritis (RA) is set to increase in value from $6.4 billion in 2013 to $9.3 billion by 2020, representing…
Irvine’s ResearchDx Signs Agreement With Micron, Inc.
ResearchDx, Inc. of Irvine, California and Micron Inc. of Tokyo, Japan have entered into an agreement for international collaborative clinical trials. The in vitro diagnostic…
Bellerophon Therapeutics Selects Flextronics to Manufacture Next-Generation Device
Bellerophon Therapeutics, Inc. recently announced it has selected Flextronics International Ltd. as its manufacturing partner for the INOpulse Mark2, the company’s next-generation pulsatile nitric oxide…
GSK & Cold Spring Harbor Laboratory to Develop Diabetes & Obesity Therapeutic
Cold Spring Harbor Laboratory (CSHL) recently announced a collaboration with GSK to develop a treatment for obesity and type 2 diabetes. Scientists at CSHL and…
CASI Pharmaceuticals Announces Initiation of Phase II Trial With ENMD-2076
CASI Pharmaceuticals, Inc. recently announced that it has initiated a Phase II trial of its target therapy drug candidate ENMD-2076 in triple-negative breast cancer (TNBC)…
Capsugel Investing More Than $25 Million in Increased Production Capacity & Quality Enhancements
Capsugel recently announced it is investing more than $25 million to increase production capacity and deliver further quality enhancements for its industry-leading vegetarian capsules. The…
Can-Fite Signs Multi-Million Dollar Distribution Agreement
Can-Fite BioPharma Ltd. recently announced it has signed a distribution agreement with Cipher Pharmaceuticals Inc. to distribute Can-Fite's lead drug candidate, CF101, for the treatment…
Confluence Pharmaceuticals Signs Co-Development & Marketing Agreement
Confluence Pharmaceuticals and AOP Orphan Pharmaceuticals AG recently announced they have signed a definitive agreement to co-develop and market Confluence’s lead asset, a product for the…
Immune Pharmaceuticals to Develop Novel Topical Nanoparticle Formulation
Immune Pharmaceuticals Inc. recently announced it has entered into a binding memorandum of understanding with Yissum, the Technology Transfer Company of the Hebrew University of…
Xcelience Receives DEA Approval to Develop & Manufacture DEA Schedule I Drug Products
Xcelience, a CDMO, located in Tampa, FL, is excited to announce that they have received approval from the Federal Drug Enforcement Agency to develop and…
Alizé Pharma III Raises $1.94 Million for Osteoporosis Program
Alizé Pharma III SAS recently announced that it has raised $1.94 million in a first financing round. The funding round was supported by a syndicate…
Cloud Pharmaceuticals & University of Florida Collaborate on Rapid Design of Novel Cancer Inhibitors
Cloud Pharmaceuticals and the University of Florida Department of Medicine recently announced an academic collaboration that will help rapidly design and develop novel drugs to…
Identification of Foreign Particulate Matter Using Automated Raman & Automated SEM-EDS
By: Angela Flowers, Emily Landsperger, Rebekah Byrne, and Dave Exline, Gateway Analytical Foreign particulate matter in drug products is a common problem in the…
Ruthigen & Pulmatrix Enter Into Merger Agreement
Ruthigen, Inc. recently announced it have entered into a definitive merger agreement. Upon the closing of the transactions contemplated by the merger agreement, Pulmatrix will…
Key TxCell Patent to be Granted for its Lead Product
TxCell SA recently announced that a key patent is to be granted by the United States Patent and Trademark Office (USPTO). The issue notification has…
